FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Cavanagh

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Merozoites

Genes & Molecular Sequences

Living Beings

Infants

Physiology

Procedures

Enzyme-Linked Immunosorbent Assay

Co-author Network

Publications

TOP 3
Natsuko Imai; Takafira MDULUZA; Nicholas Midzi; Laura J Appleby; Claire D Bourke; David Cavanagh; Graeme Cowan; Reggis Gwisai; Norman Nausch; Nadine Rujeni; David Taylor; Francisca Mutapi
Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria.
Melissa Higón; Antonio Marcilla; Oreto Antúnez; Richard J S Burchmore; David Cavanagh; Graeme Cowan; Norman Nausch; Ana Oleaga; J Russell Stothard; Rafael Toledo; Francisca Mutapi
Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.
David Cavanagh; Patrice M Dubois; Andreas Holtel; Agnes Kisser; Odile Leroy; Emily Locke; Vasee S Moorthy; Edmond J Remarque; Ya Ping Shi
Towards validated assays for key immunological outcomes in malaria vaccine development.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Cavanagh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Natsuko Imai; Takafira MDULUZA; Nicholas Midzi; Laura J Appleby; Claire D Bourke; David Cavanagh; Graeme Cowan; Reggis Gwisai; Norman Nausch; Nadine Rujeni; David Taylor; Francisca Mutapi
Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria.
Parasitology 2011;138(12):1519-33.
2011: Melissa Higón; Antonio Marcilla; Oreto Antúnez; Richard J S Burchmore; David Cavanagh; Graeme Cowan; Norman Nausch; Ana Oleaga; J Russell Stothard; Rafael Toledo; Francisca Mutapi
Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.
Parasitology 2011;138(12):1607-19.
2011: David Cavanagh; Patrice M Dubois; Andreas Holtel; Agnes Kisser; Odile Leroy; Emily Locke; Vasee S Moorthy; Edmond J Remarque; Ya Ping Shi
Towards validated assays for key immunological outcomes in malaria vaccine development.
Vaccine 2011;29(17):3093-5.
2008: David Cavanagh; Edmond J Remarque; Robert W Sauerwein; Cornelus C Hermsen; Adrian J F Luty
Influenza virosomes: a flu jab for malaria?
Trends in parasitology 2008;24(9):382-5.
2008: David E Arnot; David Cavanagh; Edmond J Remarque; Alison M Creasey; Mercy P K Sowa; William D Morgan; Anthony A Holder; Shirley Longacre; Alan W Thomas
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.
Clinical and vaccine immunology : CVI 2008;15(9):1345-55.
2008: F H A Osier; Greg Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan Thomas; David Cavanagh; Jana S McBride; David Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Infection and immunity 2008;76(5):2240-8.
2008: Carlota Dobaño; Stephen J Rogerson; Margaret J Mackinnon; David Cavanagh; Terrie E Taylor; Malcolm E Molyneux; Jana S McBride
Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.
The Journal of infectious diseases 2008;197(5):766-74.
2008: L Reilly; C Magkrioti; Takafira MDULUZA; David Cavanagh; Francisca Mutapi
Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.
BMC infectious diseases 2008;8():158.
2006: Spencer D Polley; David J Conway; David Cavanagh; Jana S McBride; Brett S Lowe; Thomas N Williams; Tabitha W Mwangi; Kevin Marsh
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Vaccine 2006;24(19):4233-46.
2005: Kevin K A Tetteh; David Cavanagh; Patrick H Corran; ROSEMARY MUSONDA; Jana S McBride; David J Conway
Extensive antigenic polymorphism within the repeat sequence of the Plasmodium falciparum merozoite surface protein 1 block 2 is incorporated in a minimal polyvalent immunogen.
Infection and immunity 2005;73(9):5928-35.
2004: David Cavanagh; Daniel Dodoo; Lars Hviid; Jørgen A L Kurtzhals; Thor G Theander; Bartholomew Akanmori; Spencer D Polley; David J Conway; Kwadwo Koram; Jana S McBride
Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.
Infection and immunity 2004;72(11):6492-502.
2004: M P Kordai Sowa; Lisa Sharling; Georgina Humphreys; David Cavanagh; William F Gregory; Katelyn Fenn; Alison M Creasey; David E Arnot
High throughput immuno-screening of cDNA expression libraries produced by in vitro recombination; exploring the Plasmodium falciparum proteome.
Molecular and biochemical parasitology 2004;133(2):267-74.
2003: Wolfram G Metzger; Daniel M N Okenu; David Cavanagh; Jane V Robinson; Kalifa Bojang; Helen A Weiss; Jana S McBride; Brian M Greenwood; David J Conway
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
Parasite immunology 2003;25(6):307-12.
2003: Denise Patricia Mawili Mboumba; Steffen Borrmann; David Cavanagh; Jana S McBride; Pierre-Blaise Matsiegui; Michel A Missinou; Song Le; Francine Ntoumi
Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria.
The Journal of infectious diseases 2003;187(7):1137-41.
2003: Spencer D Polley; Kevin K A Tetteh; David Cavanagh; Richard J Pearce; Jennifer M Lloyd; Kalifa Bojang; Daniel M N Okenu; Brian M Greenwood; Jana S McBride; David J Conway
Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.
Infection and immunity 2003;71(4):1833-42.
2002: Adriana Tami; Hajo Grundmann; C Sutherland; Jana S McBride; David Cavanagh; E Campos; Georges Snounou; C Barnabé; M Tibayrenc; david charles warhurst
Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon.
Parasitology 2002;124(Pt 6):569-81.
2002: Matthew D Baker; Anastassios C Papageorgiou; Richard Titball; Julie Miller; Sarah White; Bryan Lingard; Jeong Jin Lee; David Cavanagh; Michael A Kehoe; John Robinson; K Ravi Acharya
Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B.
The Journal of biological chemistry 2002;277(4):2756-62.
2001: David Cavanagh; Carlota Dobaño; Ibrahim M Elhassan; Kevin Marsh; Ahmed M Elhassan; Lars Hviid; Eltahir Awad Gasim Khalil; Thor G Theander; David E Arnot; Jana S McBride
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.
Infection and immunity 2001;69(2):1207-11.
2001: Kordai Mp Sowa; David Cavanagh; Alison M Creasey; Jos M H Raats; J McBride; Robert W Sauerwein; Will Roeffen; David E Arnot
Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.
Molecular and biochemical parasitology 2001;112(1):143-7.
2000: David J Conway; David Cavanagh; K Tanabe; Cally Roper; Z S Mikes; N Sakihama; Kalifa Bojang; Ayoade Oduola; Song Le; David E Arnot; Brian M Greenwood; Jana S McBride
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.
Nature medicine 2000;6(6):689-92.
1999: P N Fonjungo; Ibrahim M Elhassan; David Cavanagh; Thor G Theander; Lars Hviid; Cally Roper; David E Arnot; Jana S McBride
A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.
Infection and immunity 1999;67(6):2975-85.
1998: David Cavanagh; Ibrahim M Elhassan; Cally Roper; V J Robinson; Hayder A Giha; Anthony A Holder; Lars Hviid; Thor G Theander; David E Arnot; Jana S McBride
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(1):347-59.
1997: David Cavanagh; Jana S McBride
Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1.
Molecular and biochemical parasitology 1997;85(2):197-211.
1995: D Carroll; M A Kehoe; David Cavanagh; David C Coleman
Novel organization of the site-specific integration and excision recombination functions of the Staphylococcus aureus serotype F virulence-converting phages phi 13 and phi 42.
Molecular microbiology 1995;16(5):877-93.
1992: C Challen; K Guo; JD Collier; David Cavanagh; Margaret F Bassendine
Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas.
Journal of hepatology 1992;14(2-3):342-6.
1987: H M Arthur; David Cavanagh; P W Finch; Peter T Emmerson
Regulation of the Escherichia coli uvrD gene in vivo.
Journal of bacteriology 1987;169(8):3435-40.